Business
CSL (ASX:CSL) share price heads lower on haemophilia B deal
The CSL Limited (ASX: CSL) share price is slightly lower today despite announcing plans to buy rights for novel late-stage gene therapy candidate.
In late afternoon trade, the global biotech’s shares are swapping hands for $276.06, down 0.5%.
What did CSL announce?
Investors appear…
Continue Reading
-
Noosa News16 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
Noosa News20 hours agoQueensland Cross-Border Commissioner and former police union boss Ian Leavers found dead at Brisbane home
-
Noosa News23 hours agoDingo hunts shark in shallow waters off K’gari, Queensland
-
Noosa News19 hours agoLogan man Umar Al Enizi cleared of murder after Browns Plains road rage incident in 2021